Abstract:Autophagy is activated in the ischemic heart and is a process that is essential for survival, differentiation, development and homeostasis. 3,3'-Diindolylmethane (DIM) is a natural product of the acid-catalyzed condensation of indole-3-carbinol in cruciferous vegetables. Numerous studies have suggested that DIM has various pharmacological effects, including antioxidant, antitumor, anti-angiogenic and anti-apoptotic properties. However, the function of DIM on hypoxia-induced cardiac injury remains to be elucidated. In the present study, H9c2 cells were pretreated with DIM (1, 5 and 10 μM) for 12 h and exposed to hypoxia for 12 h. It was demonstrated that DIM markedly attenuated the increased transcription of interleukin (IL)-1β, IL-6 and tumor necrosis factor-α induced by hypoxia. In addition, the transcription of autophagy associated genes increased in the DIM pretreated group, compared with the hypoxia group. DIM additionally attenuated the increased apoptosis, as determined by terminal deoxynucleotidyl transferase dUTP nick end labeling staining, and regulated the relative protein expression level of B cell lymphoma (Bcl) 2 associated X protein, Bcl-xL and cleaved caspase 3. Furthermore, the phosphorylation of the 5' AMP-activated protein kinase a (AMPKa) was activated and the phosphorylation of c-Jun N-terminal kinase (JNK) was inhibited. The effect of DIM on hypoxia-induced apoptosis was abolished following pretreatment with JNK activator (anisomycin, 40 ng/ml). The effect of DIM on autophagy was reversed following pretreatment with AMPKa inhibitor (CpC, 20 μM) following stimulation with hypoxia. The results demonstrated that DIM prevented hypoxia‐induced inflammation and apoptosis and activated cardiomyocyte autophagy, which may be mediated by activation of AMPKa and inhibition of JNK pathways. Introduction Ischemic heart disease (IHD) is the main cause of death and disability in the world. The incidence of acute myocardial infarction (MI), a consequence of an imbalance between oxygen supply and demand, is growing in the global burden of IHD (1). Autophagy is a highly conserved intracellular degradation process that is an adaptive role to protect organisms against diverse pathologies, including infections, cancer, aging, and heart disease (2). Recent studies have showed that cardiomyocytes autophagy was activated in ischemic heart disease (3). The increase of autophagy is associated with the protective effect of ischemic preconditioning (4). However, the mechanistic process remains to be fully elucidated between myocardial ischemia and autophagy. Hence, cardiomyocytes autophagy may be a promising approach for the prevention of myocardial ischemia and progression to heart failure. 3,3'-Diindolylmethane (DIM) is extracted from natural product, derived from the acid-catalyzed condensation of indole-3-carbinol in cruciferous vegetables. Numerous studies have suggested that DIM has various pharmacological effects, including antioxidant, antitumor, anti‐angiogenic, anti‐inflammatory and anti-apoptotic (5-8). Meanwhile DIM could affect AMPKα and JNK signaling pathway (9,10). DIM could inhibit the proliferation of cancer cells through modulating autophagy (11). The previous studies showed that DIM attenuated TGFβ1-induced myofibroblast differentiation through down-regulated AKT/GSK-3β signaling pathways (12). The cardioprotective effects of DIM on cardiac hypertrophy are partly mediated through AMPKa signaling (13). It also improved myocardial energy metabolism imbalance induced by pressure overload via AMPKα in mice (14). All these studies indicate the protective effect of DIM on cardiovascular disease. However, it remains unknow whether DIM would protect cardiomyocyte from hypoxia injury. The purpose of the study was to evaluate the effect of DIM on hypoxia injury in cardiomyocytes and the underlying mechanism. Materials and methods Materials. The primary antibodies included phosphorylated (p)-AMPKα (sc101631; Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA), T-AMPKα (BS4046, BS1061, BS6271, respectively; Bioworld Technology Inc., St. Louis Park, 3,3'‐Diindolylmethane attenuates cardiomyocyte hypoxia by modulating autophagy in H9c2 cells KAI LIANG1,2, WEN-HAO QIAN1,2 and JING ZONG1,2 1Institute of Cardiovascular Disease Research, Xuzhou Medical University; 2Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu 221002, P.R. China Received December 2, 2016; Accepted June 1, 2017 DOI: 10.3892/mmr.2017.7788 Correspondence to: Mr. Wen-Hao Qian, Department of Cardiology, The Affiliated Hospital of Xuzhou Medical University, 99 West Huaihai Road, Xuzhou, Jiangsu 221002, P.R. China E-mail: DR63263907@163.com

3,3′-Diindolylmethane Protects Against Cardiac Hypertrophy Via 5′-Adenosine Monophosphate-Activated Protein Kinase-α2

3,3'-Diindolylmethane Attenuates Cardiac H9c2 Cell Hypertrophy Through 5'-Adenosine Monophosphate-Activated Protein Kinase-Α.

DIM Attenuates TGF-β1-induced Myofibroblast Differentiation in Neonatal Rat Cardiac Fibroblasts.

3,3′-Diindolymethane Ameliorates Adriamycin-Induced Cardiac Fibrosis Via Activation of a BRCA1-dependent Anti-Oxidant Pathway

Prevent Diabetic Cardiomyopathy in Diabetic Rats by Combined Therapy of Afgf-Loaded Nanoparticles and Ultrasound-Targeted Microbubble Destruction Technique.

Combined Treatment with Ultrasound-Targeted Microbubble Destruction Technique and NM-aFGF-loaded PEG-nanoliposomes Protects Against Diabetic Cardiomyopathy-Induced Oxidative Stress by Activating the AKT/GSK-3β1/Nrf-2 Pathway

Diindolylmethane attenuates cardiomyocyte hypoxia by modulating autophagy in H 9 c 2 cells

Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase

Attenuation of doxorubicin-induced cardiotoxicity and genotoxicity by an indole-based natural compound 3,3′-diindolylmethane (DIM) through activation of Nrf2/ARE signaling pathways and inhibiting apoptosis

Indole-3-carbinol protects against pressure overload induced cardiac remodeling via activating AMPK-α.

Intermedin Suppresses Pressure Overload Cardiac Hypertrophy Through Activation Of Autophagy

Dihydromyricetin Prevents Diabetic Cardiomyopathy via miR-34a Suppression by Activating Autophagy

Dihydromyricetin protects against Doxorubicin-induced cardiotoxicity through activation of AMPK/mTOR pathway

3,3′-Diindolylmethane promotes bone formation – A assessment in MC3T3-E1 cells and zebrafish

Intermedin Alleviates Diabetic Cardiomyopathy by Up-Regulating CPT-1β through Activation of the Phosphatidyl Inositol 3 Kinase/Protein Kinase B Signaling Pathway

3,3′‐Diindolylmethane Ameliorates Experimental Hepatic Fibrosis Via Inhibiting Mir‐21 Expression

Diosmetin Protects against Cardiac Hypertrophy via p62/Keap1/Nrf2 Signaling Pathway

Epigenetic Modifications of Nrf2 by 3,3′-Diindolylmethane in Vitro in TRAMP C1 Cell Line and in Vivo TRAMP Prostate Tumors

Protective effect of diindolylmethane‐enriched dietary cabbage against doxorubicin‐induced cardiotoxicity in mice

Hepatoprotective Effects of a Natural Flavanol 3,3'-Diindolylmethane against CCl4-Induced Chronic Liver Injury in Mice and TGFβ1-Induced EMT in Mouse Hepatocytes via Activation of Nrf2 Cascade

Effect of Intermedin(1-53) on Angiotensin Ii-Induced Hypertrophy in Neonatal Rat Ventricular Myocytes